Who has invested in Alpha Biopharma?

Qiming Venture Partners, TF Fund, LYZZ Healthcare Venture Fund are named among the investors backing Alpha Biopharma.

Alpha Biopharma Funding: $124M Raised, Series A (2018)

Alpha Biopharma funding overview

Alpha Biopharma is based in Shanghai, China. Alpha Biopharma has raised $124M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in June 2018. The round record for Alpha Biopharma runs through 2018; nothing later has been disclosed. Investors on record include Qiming Venture Partners, TF Fund, LYZZ Healthcare Venture Fund. 3 distinct backers are named across the disclosed rounds.

Alpha Biopharma at a glance

Total raised: $124M
Latest round: Series A
Latest round date: June 2018
Headquarters: Shanghai, China
Notable investors: Qiming Venture Partners, TF Fund, LYZZ Healthcare Venture Fund

Frequently asked about Alpha Biopharma funding

How much has Alpha Biopharma raised?: Alpha Biopharma has raised $124M in total disclosed funding across the rounds on record.
Who has invested in Alpha Biopharma?: Qiming Venture Partners, TF Fund, LYZZ Healthcare Venture Fund are named among the investors backing Alpha Biopharma.
What was the latest Alpha Biopharma funding round?: The most recent disclosed round is a Series A, announced in June 2018.
Where is Alpha Biopharma based?: Alpha Biopharma is based in Shanghai, China.
When did Alpha Biopharma last raise?: The last disclosed Alpha Biopharma round closed in June 2018 at Series A.

We update the Alpha Biopharma record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Shanghai and their backers are listed below.

Alpha Biopharma Funding: $124M Raised, Series A (2018)

Alpha Biopharma funding overview

Alpha Biopharma at a glance

Frequently asked about Alpha Biopharma funding

Companies related to Alpha Biopharma (35)

Browse related funding lists (6)